NASDAQ:FENC

Fennec Pharmaceuticals Stock News

etoro logo Buy FENC
*Your capital is at risk
$9.14
-0.84 (-8.42%)
At Close: Jun 03, 2026
Los Angeles, California--(Newsfile Corp. - October 28, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Fennec Pharmac
Los Angeles, California--(Newsfile Corp. - October 27, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Fennec Pharmac
New York, New York--(Newsfile Corp. - October 26, 2020) -  The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities
LOS ANGELES, CA / ACCESSWIRE / August 19, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Fennec Pharmace
The law firm of Kirby McInerney LLP is investigating potential claims against Fennec Pharmaceuticals Inc. ("Fennec" or the "Company") (NASDAQ: FENC). The investigation concerns whether Fennec and cert
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Fennec Pharmaceuticals, Inc. (NASDAQ: FENC) on behalf of Fennec stockholders
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Fennec Pharmaceuticals Inc.
NEW YORK, NY / ACCESSWIRE / August 17, 2020 / Pomerantz LLP is investigating claims on behalf of investors of Fennec Pharmaceuticals Inc.
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Fennec Pharmaceuticals Inc. on Behalf of Investors
The Law Offices of Frank R. Cruz announces an investigation on behalf of Fennec Pharmaceuticals Inc. ("Fennec" or the "Company") (NASDAQ: FENC) investors concerning the Company’s possible violations
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Fennec Pharmaceuticals Inc. (FENC) on Behalf of Investors
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Fennec Pharmaceuticals Inc.
Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Fennec Pharmaceuticals Inc. (NASDAQ: FENC) resulting from alle
Pomerantz LLP is investigating claims on behalf of investors of Fennec Pharmaceuticals Inc. ("Fennec" or the "Company") (NASDAQ: FENC). Such investors are advised to contact Robert S. Willoughby at rs
The following slide deck was published by Fennec Pharmaceuticals Inc. in conjunction with this event..
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE